受训医师与专科医师管理新生血管性年龄相关性黄斑变性的比较:一项基于登记的研究
这项前瞻性多中心登记观察研究比较了受训医师主导与专科医师主导管理新生血管性年龄相关性黄斑变性(nAMD)的结局。纳入726只眼(受训组534只,专科组192只),12个月视力变化差异无统计学意义(+3.2 vs +4.1字母,差异-0.9字母,95%CI -3.4至1.5,p=0.473),36个月亦无显著差异;受训组平均注射次数较少(15.0 vs 19.0,p=0.004),但该趋势仅见于一个中心。结论认为在规范结构下受训医师主导管理nAMD是合理方法。
要点
- 受训医师与专科医师管理的nAMD眼在12个月和36个月视力变化均无显著差异。
- 受训组至36个月平均注射次数少于专科组(15.0 vs 19.0,p=0.004),但仅一个中心呈现此趋势。
- 在监管和实际条件允许时,结构合理的受训医师主导nAMD管理是合理方法。
核心结论
- 受训医师与专科医师管理的nAMD眼在视力结局上无显著差异,结构合理的受训医师主导管理是合理方法。
研究设计与样本
- 前瞻性多中心登记观察研究,纳入澳大利亚和欧洲的眼科培训中心中初治nAMD且随访至少12个月的眼。
- 共纳入726只眼,其中534只接受受训医师主导治疗,192只接受专科医师主导治疗。
主要发现
- 12个月视力调整后变化:受训组+3.2字母,专科组+4.1字母,差异-0.9字母(95%CI -3.4至1.5,p=0.473)。
- 36个月视力调整后变化:受训组-0.9字母,专科组+0.2字母,差异-1.1字母(95%CI -5.1至2.9,p=0.596)。
- 至36个月平均注射次数:受训组15.0次,专科组19.0次(p=0.004),但该趋势仅见于一个中心。
临床怎么用
- 在监管和实际条件允许的培训中心,可考虑采用结构合理的受训医师主导nAMD管理模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the outcomes of trainee-led and specialist-led management of neovascular age-related macular degeneration. DESIGN: Prospective multicentre registry-based observational study. SETTING: Ophthalmology training centres in Australia and Europe where both trainee-led and specialist-led models of care coexist. PARTICIPANTS: Treatment-naïve eyes with neovascular age-related macular degeneration and at least 12 months follow-up. 726 eyes were included in the study from two centres, 534 receiving trainee-led treatment and 192 specialist-led treatment. INTERVENTIONS: The management and outcomes of patients receiving trainee-led care were compared with those receiving specialist-led care. MAIN OUTCOMES MEASURES: The primary outcome was the mean change in visual acuity at 12 months from first injection. Outcomes were also presented at 36 months where available. RESULTS: The mean age of participants was 79 years and 65% were female. The adjusted change in acuity at 12 months in trainee-led vs specialist-led eyes was +3.2 letters vs +4.1 letters (difference -0.9 letters, 95% CI -3.4 to 1.5, p=0.473). The mean adjusted change in acuity at 36 months was -0.9 letters in trainees vs +0.2 letters for specialists (difference -1.1 letters, 95% CI -5.1 to 2.9, p=0.596). Eyes treated by trainees received fewer injections on average to 36 months (15.0 vs 19.0, p=0.004), although this trend was observed at one centre only. CONCLUSIONS: No significant differences in outcome between eyes managed by trainees and eyes managed by specialists were observed. Appropriately structured trainee-led management of neovascular age-related macular degeneration is a reasonable approach where regulatory and practical considerations allow it.
引用
- Essex RW, Nguyen V, Daien V, et al. Trainee-led versus specialist-led management of neovascular age-related macular degeneration: a registry-based study. Br J Ophthalmol. 2018. PMID: 30385435. doi:10.1136/bjophthalmol-2018-311852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。